Porton Pharma controllers pledge, release shares; no control change

Porton Pharma Solutions (SZSE:300363) announced that controlling shareholders Ju Nianfeng and Zhang Hebing conducted pledge and release transactions involving the company's shares. Zhang Hebing pledged 550,000 shares, 250,000 shares and 521,000 shares on various dates this year, while Ju Nianfeng pledged 1,147,000 shares on June 16th. Simultaneously, they released a total of 1,581,000 previously pledged shares. The announcement specified the purposes of the pledges are for repaying previous debts and interest. As of the disclosure date, the total pledged shares held by Ju Nianfeng, Tao Rong and Zhang Hebing amounted to 69,978,500, representing 48.26% of their holdings and 12.83% of the company’s total share capital, with a corresponding financing balance of CNY4.313 billion. Porton Pharma emphasized that these activities do not affect the company's operations or governance and there are no risks of forced liquidation or a change in control.